SAN FRANCISCO, April 19, 2012 /PRNewswire/ -- Utilization management (UM) programs such as prior authorizations (PAs) can be used to improve safety and efficacy as well as cost-effectiveness for specialty drugs, according to two new studies being presented tomorrow by Prime... read more..
Solta Medical's Clear + Brilliant™ Resurfacing Device Demonstrates Significant Reduction of Pore Count and Pore Size
HAYWARD, Calif., April 19, 2012 /PRNewswire/ -- Solta Medical, Inc. (Nasdaq: SLTM), the pioneer in fractional resurfacing and a global market leader in aesthetic treatments, today announced the results of a first-of-its-kind, IRB-approved clinical study that evaluated the use of its... read more..
InterMune To Release First Quarter Financial Results On April 26
BRISBANE, Calif., April 19, 2012 /PRNewswire/ -- InterMune, Inc. (NASDAQ: ITMN) today announced that it will release its first quarter 2012 financial results at the close of the U.S. markets on Thursday, April 26, 2012. A live conference call and webcast will be hosted by... read more..